MedNews

  • Drug Industry News
  • FDA News & Alerts
  • Health & Medical News
You are here: Home / Health & Medical News / Cancer / Obesity Drug Orlistat (Xenical) May Aid in Cancer Treatments

Obesity Drug Orlistat (Xenical) May Aid in Cancer Treatments

July 10, 2007 By MedNews Leave a Comment

Five years ago, scientists at Wake Forest University School of Medicine were surprised to find the drug orlistat (Xenical or Alli) could kill cancer cells. Now, they report on how it works. The drug binds and interacts with a protein found in tumor cells, blocking its function and causing the cells to die.

Researches point out that Orlistat alone can not treat cancer, as it can act only in the digestive tract in humans. However, a greater understanding of how Orlistat functions with cancer cells may help in the development of a drug like orlistat that can go through the bloodstream to the site of the tumor.

Filed Under: Cancer Tagged With: Alli, cancer, obesity, orlistat, Xenical



Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search



Tag Cloud

alcohol alzheimers asthma breast cancer cancer children cholesterol dementia depression Diabetes diet drug abuse exercise fda flu food genetics geriatrics h1n1 heart heart attack heart disease high blood pressure HIV/AIDS hormone therapy hypertension lungs menopause mrsa NIH obesity pain pediatrics pregnancy prostate cancer seniors sleep smoking statistics stroke sun swine flu teens USA women's health

Recent Comments

  • Mia Fritz on Health Benefits of Dark Chocolate
  • Shilpa on Why Too Much Iron Can Be Dangerous
  • Racheal on Teen Pregnancy May Be Reduced by Sex Education in Schools, Says Study
  • Don on Prilosec, Nexium and Prevacid Tied to Higher Risk of Pneumonia
  • Meso on Brain Changes in Elderly Can Affect Mobility and Balance
  • About Us
  • Contact

Copyright © 2021 Mednews · Log in